Related Experiment Videos
Visit-to-visit systolic blood pressure variability, blood pressure treatment intensity, and cognitive decline
Yue Qiao1, Zihan Sun2, Xunming Ji3
1Department of Neurology, Xuanwu Hospital Capital Medical University, National Centre for Neurological Disorders, Beijing, China.
Insights
Higher blood pressure variability (BPV) is linked to faster cognitive decline, independent of average blood pressure (BP). This association was noted in intensive BP treatment arms, suggesting BPV may impact cognition differently based on treatment intensity.
Area of Science:
- Cardiovascular Research
- Neurology
- Clinical Trials
Background:
- Visit-to-visit blood pressure variability (BPV) may impact cognitive function beyond average blood pressure (BP).
- The role of BPV in cognitive decline across different blood pressure treatment strategies is not well understood.
Purpose of the Study:
- To investigate the association between systolic blood pressure variability independent of the mean (SBP-VIM) and cognitive decline.
- To explore whether this association differs between intensive and standard blood pressure treatment contexts.
Main Methods:
- Pooled individual participant data from ACCORD-MIND and SPRINT-MIND trials (n=11,104).
- Assessed SBP-VIM as the primary exposure and annualized cognitive decline (Digit Symbol Substitution or Coding Test Z-scores) as the primary outcome.
- Included baseline and follow-up cognitive testing and multiple BP measurements.
Main Results:
- A 10% increase in SBP-VIM was independently associated with accelerated annual cognitive decline (β = -0.008 per year).
- This association was observed in intensive blood pressure treatment arms but not in standard treatment arms.
- The pooled interaction between SBP-VIM and treatment intensity was not statistically significant (p=0.054).
Conclusions:
- Elevated systolic BPV is associated with faster cognitive decline, independent of mean systolic BP.
- Exploratory findings suggest a potential differential impact of BPV on cognition based on treatment intensity, requiring further investigation.
Introduction:
Visit-to-visit blood pressure variability (BPV) may be associated with cognitive decline beyond mean blood pressure (BP), but its relevance across treatment contexts remains uncertain.
Methods:
We pooled individual-participant data from Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes (ACCORD-MIND) and Systolic Blood Pressure Intervention Trial Memory and Cognition in Decreased Hypertension (SPRINT-MIND) (n = 11,104). Participants had baseline and follow-up cognitive testing and ≥3 BP measurements from 3 months onwards. The primary exposure was systolic BP variation independent of the mean (SBP-VIM). The primary outcome was annualized change in standardized Digit Symbol Substitution or Coding Test Z-scores.
Results:
Each 10% increment in SBP-VIM was independently associated with faster annual cognitive decline (β = -0.008 per year; 95% confidence interval [CI]: -0.014 to -0.003) after adjustment including mean SBP. Associations were observed in the intensive but not standard BP treatment arms of both trials, although the pooled interaction was not statistically significant (p = 0.054).
Discussion:
Higher systolic BPV was associated with accelerated cognitive decline independently of mean BP. The exploratory treatment-context pattern warrants prospective confirmation.
Related Concept Videos
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Factors affecting Blood pressure
Physiological Factors:
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pre-Procedural Guidelines for Assessing Blood Pressure
Errors occurring during blood pressure monitoring
Several factors...
Assessing Blood pressure in the Leg
Preparation: